Hassan's pressure moves drug firm to end monopoly over child asthma inhaler
A major pharmaceutical company ended price hikes and monopoly protection over its life-saving asthma inhaler widely used by children following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H.